top of page

Devastating Impact on Patients and Medical Science from Government Price Controls

Government price controls will lead to sharp declines in U.S. clinical trial research for major public health issues like cancer, Alzheimer's, and obesity threatening patient access to new medicines, according to a new U.S. Chamber study.


Comments


bottom of page